WHO Approves First Mpox Diagnostic Test For Emergency Use, Boosting Global Access; The Approval For Emergency Use Of The Alinity M MPXV Assay, Manufactured By Abbott Molecular Inc. - WHO
Portfolio Pulse from Benzinga Newsdesk
The World Health Organization (WHO) has approved the first mpox diagnostic test, the Alinity m MPXV assay by Abbott Molecular Inc., for emergency use. This approval aims to enhance global access to mpox testing, especially in regions with high outbreak rates. The test is a real-time PCR assay designed for use by trained laboratory personnel to confirm mpox cases efficiently.
October 03, 2024 | 7:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Molecular Inc.'s Alinity m MPXV assay has been approved by WHO for emergency use, marking a significant step in expanding mpox testing globally. This approval could boost Abbott's market presence in the diagnostic sector.
The WHO's approval of Abbott's Alinity m MPXV assay for emergency use is a significant endorsement, likely to enhance Abbott's reputation and market share in the diagnostics field. The test addresses a critical need in regions with mpox outbreaks, potentially increasing demand for Abbott's diagnostic products.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90